Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene Gel 0.1% vs Differin in Acne Vulgaris
NCT04797793Phase 1Completed
- Start
- May 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of adapalene in acne vulgaris (3 arms). Primary endpoint: The percentage change in the inflammatory and non-inflammatory lesion counts at 12 weeks. Started May 2020; status: completed.
02
Drugs
adapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04797793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797793.